21st Jun 2018 09:17
LONDON (Alliance News) - Physiomics PLC said Thursday it is trading "ahead of market expectations" for its financial year to the end of June.
The company, which provides technology to predict the effects cancer treatment regimens, said total income is "likely to be greater" than GBP495,000, while its loss will be "materially reduced".
For the year ended June 2017, Physiomics posted total income of GBP270,465 and a pretax loss of GBP530,399.
Chief Executive Officer Jim Millen said: "We are pleased that as a result of the hard work of the team, the company continues to show progress not only in attracting new clients but in translating this into bookable revenue which is moving us closer to profitability."
Physiomics shares were trading 1.3% higher at 4.36 pence each early Thursday morning.
Related Shares:
Physiomics